CBMG

Cellular Biomedicine (CBMG)

Cellular Biomedicine Group Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CBMG

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/03/04	04 : 40	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/26	20 : 14	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/26	20 : 12	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/26	20 : 11	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/22	20 : 02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	06 : 11	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 45	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 11	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 10	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 08	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 07	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 07	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	05 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/20	04 : 55	PR Newswire (US)	Cellular Biomedicine Group, Inc. Announces Completion of Merger	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/09	06 : 19	PR Newswire (US)	Cellular Biomedicine Group, Inc. Stockholders Approve Merger	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/02	04 : 50	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/02/01	22 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/01/29	20 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/01/29	06 : 30	PR Newswire (US)	Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2021/01/27	07 : 21	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2020/12/30	06 : 20	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:CBMG	Cellular Biomedicine Group Inc
2020/12/30	06 : 11	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:CBMG	Cellular Biomedicine Group Inc